Live feed

Health & Drug Safety News

FDA alerts, drug recalls, new research, and policy updates — explained in plain English, updated daily.

Drug SafetyApril 7, 2026 · FDA

FDA Issues New Warning on GLP-1 Drug Interactions With Common Blood Pressure Medications

The agency updated prescribing guidance for semaglutide and liraglutide after post-market surveillance identified increased hypotension risk in patients concurrently using ACE inhibitors. Millions of Americans take both drug classes simultaneously.

Read full story →
Addiction2 hours ago

Naloxone Over-the-Counter Availability Expands to 12 New States

The life-saving opioid reversal drug is now available without a prescription in 12 additional states, bringing the total to 38. Here’s how to get it and when to use it.
Policy4 hours ago

Senate Passes Drug Pricing Transparency Act — What It Means for Your Prescriptions

The bill requires pharma companies to justify price increases above 10% annually. Analysts expect modest reductions for 18 commonly prescribed medications within two years.
Recall Alert6 hours ago

Recall Alert: Three Lots of Metoprolol Succinate Withdrawn Over Potential Contamination

Zydus Pharmaceuticals has voluntarily recalled three lots of the blood pressure drug due to foreign particulate contamination. Distributed nationally January–March 2026.
ResearchYesterday

New Study Links Long-Term Benzo Use to 38% Higher Dementia Risk in Over-60s

A 15-year longitudinal study in JAMA Neurology found adults over 60 using benzodiazepines daily for more than 3 years showed significantly elevated Alzheimer’s-type dementia risk.
Drug SafetyYesterday

Adderall Shortages Continue Into Q2 2026 — What Patients Need to Know

DEA production quotas and manufacturer delays have extended the national shortage. Doctors can consider Ritalin and Vyvanse, which remain in adequate supply.
Research2 days ago

Phase 3 Trial Shows CRISPR Treatment Cures Sickle Cell Disease in 94% of Patients

The landmark results confirm earlier data — a one-time gene-editing treatment eliminates pain crises in the majority of participants with no serious adverse events at 24-month follow-up.
Addiction2 days ago

Fentanyl Test Strips Now Legal in All 50 States

After the last holdout state repealed its paraphernalia law, harm reduction advocates say wider test strip access could prevent thousands of overdose deaths annually.